Staar Surgical (STAA) Cash from Investing Activities (2010 - 2026)

Staar Surgical's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $2.1 million for Q2 2026.

• Quarterly Cash from Investing Activities fell 93.93% year-over-year to $2.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $13.1 million (up 132.79% YoY) and the FY2026 annual result came in at $46.3 million, up 178.25% from the prior year.
• Cash from Investing Activities was $2.1 million for Q2 2026 at Staar Surgical, up from -$19.4 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $35.4 million in Q1 2025 and bottomed at -$101.8 million in Q3 2022.
• A 5-year average of -$5.5 million and a median of $2.1 million in 2026 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 3011.79% — and 2023, when it soared 491.22%.
• Staar Surgical's Cash from Investing Activities stood at -$46.7 million in 2022, then jumped by 147.95% to $22.4 million in 2023, then slumped by 187.02% to -$19.5 million in 2024, then surged by 127.1% to $5.3 million in 2025, then sank by 59.36% to $2.1 million in 2026.
• Business Quant data shows STAA's Cash from Investing Activities at $2.1 million in Q2 2026, -$19.4 million in Q1 2026, and $5.3 million in Q3 2025.